Journals / Uludağ Üniversitesi Tıp Fakültesi Dergisi / 2020 / Cilt: 46 - Sayı: 1

Effect of Diallyl Disulfide on Doxorubicin-induced Follicular Apoptotic Activation in Rat Ovarian Tissue

Sıçan Ovaryum Dokusunda Doksorubisin ile İndüklenmiş Folliküler Apoptotik Aktivasyonda Dialil Disülfit’in Koruyucu Etkisi

Pages
1–8
Publication Date
2020-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was concluded that dialyl disulfide treatment may reduce doxoru-bicin-induced ovarian toxicity and may be effective in maintaining ovarian follicular reserve.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to determine the toxicity of doxorubicin, an important chemotherapeutic agent, on the ovary and to evaluate the efficacy of dialyl disulfide which has high antioxidant capacity on ovarian toxicity.
📊
Key Findings & Data:In this study, 35 female Wistar albino rats were divided into 5 subgroups: Group I: Control-Doxorubicin Group, Group II: Control-Dialyl disulfide Group, Group III: Doxorubicin Applied Group, Group IV: Diallyl disulfide Applied Group, Group V: Doxorubicin + Diallyl disulfide Group.
💡
Conclusion & Impact:It was concluded that dialyl disulfide treatment may reduce doxoru-bicin-induced ovarian toxicity and may be effective in maintaining ovarian follicular reserve.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:apoptoz · Dialil disülfit · Doksorubisin

Abstract

The aim of this study was to determine the toxicity of doxorubicin, an important chemotherapeutic agent, on the ovary and to evaluate the efficacy of dialyl disulfide which has high antioxidant capacity on ovarian toxicity. In this study, 35 female Wistar albino rats were divided into 5 subgroups: Group I: Control-Doxorubicin Group, Group II: Control-Dialyl disulfide Group, Group III: Doxorubicin Applied Group, Group IV: Diallyl disulfide Applied Group, Group V: Doxorubicin + Diallyl disulfide Group. Morphological evaluation was performed with hematoxylin eosin staining. Apoptotic activation was evaluated by TUNEL method. Doxorubicin caused a decrease in the number of primor-dial, secondary and graaf follicles, and increased atretic follicle counts. It was concluded that dialyl disulfide treatment may reduce doxoru-bicin-induced ovarian toxicity and may be effective in maintaining ovarian follicular reserve.

Özet

Bu çalışmada önemli bir kemoterapötik ajan olan doksorubisinin ovaryum üzerindeki toksisitesini belirlemek ve ovaryan toksisite üzerine yüksek antioksidan kapasiteye sahip olan dialil disülfitin etkinliğini değerlendirmek amaçlandı. Çalışma kapsamında 35 adet Wistar albino cinsi dişi sıçan 5 alt gruba ayrıldı: Grup I: Kontrol-Doksorubisin Grubu, Grup II: Kontrol-Dialil disülfit Grubu, Grup III: Doksorubisin Uygulanan Grup, Grup IV: Dialil disülfit Uygulanan Grup, Grup V: Doksorubisin + Dialil disülfit Uygulanan Grup. Morfolojik değerlendir-me hematoksilen eozin boyaması ile gerçekleştirildi. Apoptotik aktivasyon TUNEL yöntemi ile değerlendirildi. Doksorubisin uygulamasının primordiyal, sekonder ve graaf follikül sayılarında azalmaya sebep olduğu gözlemlenirken, atretik follikül sayılarını ise arttırdığı saptandı. Dialil disülfit tedavisinin doksorubisin ile indüklenmiş ovaryan toksisiteyi azaltabileceği ve ovaryan follikül rezervinin korunmasında etkili olabileceği sonucuna varıldı.

🔖

Cite This Article

ŞEN, E., SAYGI, S. S., ÖNAL, A., AKBAŞ, A., AVCI, B., KAHVECİ, Z. (2020). Effect of Diallyl Disulfide on Doxorubicin-induced Follicular Apoptotic Activation in Rat Ovarian Tissue. Uludağ Üniversitesi Tıp Fakültesi Dergisi, Cilt: 46 - Sayı: 1, 1–8. https://ajindex.com/articles/134742

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Mohan P, Rapoport N. Doxorubicin as a Molecular Nanotheranostic Agent: Effect of Doxorubicin Encapsulation in Micelles or Nanoemulsions on the Ultrasound-Mediated Intracellular Delivery and Nuclear Trafficking. Mol Pharm. 2010;7(6):1959-73.
  2. Arcamone F, Cassinelli G, Fantini G et al. Adriamycin, 14-Hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol Bioeng. 2000;67(6):704-13.
  3. Bendale Y, Bendale V, Paul S. Evaluation of cytotoxic activity of platinum nanoparticles against normal and cancer cells and its anticancer potential through induction of apoptosis. Integr Med Res. 2017;6(2):141-48.
  4. Vallejo MJ, Salazar L, Grijalva M. Oxidative Stress Modulation and ROS-Mediated Toxicity in Cancer: A Review on In Vitro Models for Plant-Derived Compounds. Oxidative Medicine and Cellular Longevity. 2017;doi:10.1155/2017/4586068. Louis J, Limarzi LR, Best WR. Treatment of Chronic Granulocytic Leukemia with Myleran. A.M.A Archives of Internal Medicine. 1957;97(3):299-08.
  5. Falcone T, Attaran M, Bedaiwy MA, Goldberg JM. Ovarian Function Preservation in the Cancer Patient. Fertil Steril. 2004;81(2):243-57. Blumenfeld Zeev. Chemotherapy and Fertility. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):379-90.
  6. Irving-Rodgers HF, Krupa M, Rodgers RJ. Cholesterol Side-Chain Cleavage Cytochrome P450 and 3β-Hydroxysteroid Dehydrogenase Expression and the Concentrations of Steroid Hormones in the Follicular Fluids of Different Phenotypes of Healthy and Atretic Bovine Ovarian Follicles. Biol Reprod. 2004;69(6):2022-28.
  7. Adaki S, R Adaki, K Shah, Karagir A. Garlic: Review of Literature. Indian J Cancer. 2014;51(4):577-81. Pedraza-Chaverrí J, González-Orozco AE, Maldonado PD, Barrera D, Medina-Campos ON, Hernández-Pando R. Diallyl Disulfide Ameliorates Gentamicin-Induced Oxidative Stress and Nephropathy in Rats. Eur J Pharmacol. 2003;473(1):71-78.
  8. Ross MH, Pawlina W. Histology A Text And Atlas with Corralated Cell and Molacular Biology. 6th edition. LWW. 2011. 833-837.
  9. Losa M, Barzaghi RL, Mortini P, Franzin A, Mangili F, Terreni MR, Giovanelli M. Determination of the Proliferation and Apoptotic Index in Adrenocorticotropin-Secreting Pituitary Tumors Comparison between Micro- and Macroadenomas. Am J Pathol. 2000;156(1):245-51.
  10. Maltaris T, Seufert R, Fischl F et al. The Effect of Cancer Treatment on Female Fertility and Strategies for Preserving Fertility. Eur J Obstet Gynecol Reprod Biol. 2007; 130(2):148-55.
  11. Oktem O, Oktay K. A Novel Ovarian Xenografting